WHO Panel Recommends AstraZeneca Vaccine Despite Variant Concerns

The New York Times | Feb. 10, 2021, 2:32 p.m. | Original

The guidance came days after South Africa announced that it would halt its rollout of the AstraZeneca vaccine over concern about its efficacy against a new variant.

Rihanna and LVMH Hit Pause on Fenty, Their Fashion Line New Zealand Maori Lawmaker Ejected From Parliament for Not Wearing Tie